Investors & Media

Corporate Profile

Abeona Therapeutics is focused on developing and delivering gene therapy products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases such as Sanfilippo syndrome, Epidermolysis Bullosa, Batten disease, Fanconi anemia and other rare disorders.

Events & Presentations

Jefferies 2018 Global Healthcare Conference
June 5 - 8, 2018 in New York, NY
11:00am, Jefferies Presentation (PDF Link)
Webcast: http://wsw.com/webcast/jeff113/abeo/index.aspx

International Investigative Dermatology
May 16 - 19, 2018 in Orlando, FL

21st Annual ASGCT Meeting
May 16 - 19, 2018 in Chicago, IL
EB Presentation (PDF)
MPSIIIA Presentation (PDF)

Abeona First Quarter 2018 Earnings Call & Business Update
Monday, May 14th at 10:00 am ET
877-407-9210 (toll free domestic)
201-689-8049 (International)
Webcast: http://www.investorcalendar.com/event/29196

Bloomberg Biotech Innovations Conference
Monday, April 9, 2018 in New York, NY
Abeona Presentation: 2:30pm ET
Event will be streamed live on the Bloomberg terminal
Link: http://b.bloomberg.com/reg-BiotechInnovations?src=SA

Investor & Media Contact

Christine Silverstein
Senior Vice President
Finance & Investor Relations

+1 (646) 813-4707
csilverstein@abeonatherapeutics.com

IR Documents

IR Links & Resources